. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Clinical Trials as TopicDouble-Blind MethodHumansMyocardial Infarction/mortalityMyocardial Infarction/prevention & controlRandom AllocationRecurrenceSulfinpyrazone/therapeutic use
Substances： See more » Sulfinpyrazone
Year: 1982 PMID： 6122022 DOI： 10.1016/s0140-6736(82)92639-3
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321